Data highlights PYLARIFY’s ability to detect recurrent prostate cancer in patients with low PSA Real-world evidence of PYLARIFY’s effectiveness in prostate cancer being presented BEDFORD, Mass., Feb.

The Oral Health Section of The Department of Health will hold its inaugural Bermuda Oral Health Symposium, on February 6 and ...

Orchard Therapeutics, a Kyowa Kirin company, today announced presentations from seven abstracts from across its hematopoietic stem cell (HSC) gene therapy portfolio will be featured at the 21st Annual ...

PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral presentations and 20 posters across its development programs will be included at ...

The Rubber Division invites your submissions for inclusion in our Global Polymer Summit Technical Meeting & Student Symposium, September 9-11 in Cleveland, OH. Combining the strengths of Rubber ...

WARNING: SEVERE HYPERSENSITIVITY REACTIONS Hypersensitivity Reactions Including Anaphylaxis Patients treated with Lamzede have experienced hypersensitivity reactions, including anaphylaxis.

The three-day event aims to foster dialogue on innovative mitigation strategies to safeguard the marine environment and promote sustainable practices.

ISMH17 will be held in Rotterdam, The Netherlands offering opportunities for professionals in or related to maritime health to present their research and share valuable insights. Your submission will ...

Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposium Eight abstracts discussing data and clinical experience associated with MIPLYFFA accepted for poster ...

Applications for the 2025 Undergraduate Research Symposium opened Jan. 8 and will close Feb. 13. The May 16 event marks the ...